William M. Winston - Concepedia

Author

William M. Winston

AVEO Oncology (United States)ORCID

Also Known As

W. Winston, W.M. WINSTON, William M Winston, William M. Winston, William Winston

117

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

AVEO Oncology (United States)GlycoMira Therapeutics (United States)Harvard University

About

William M. Winston is an author at AVEO Oncology (United States).

William M. Winston

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Systemic RNAi in <i>C. elegans</i> Requires the Putative Transmembrane Protein SID-1 William M. Winston, Christina Molodowitch, Craig P. Hunter Science	2002	855
<i>Caenorhabditis elegans</i> SID-2 is required for environmental RNA interference William M. Winston, Marie E. Sutherlin, Amanda J. Wright, Proceedings of the National Academy of Sciences	2007	321
MAP3K11/GDF15 axis is a critical driver of cancer cachexia Lorena Lerner, Julie Tao, Qing Liu, Journal of Cachexia Sarcopenia and Muscle	2015	174
GP369, an FGFR2-IIIb–Specific Antibody, Exhibits Potent Antitumor Activity against Human Cancers Driven by Activated FGFR2 Signaling Ailin Bai, Kristan Meetze, Nhi Vo, Cancer Research	2010	146
Neuregulin 1 Expression Is a Predictive Biomarker for Response to AV-203, an ERBB3 Inhibitory Antibody, in Human Tumor Models Kristan Meetze, Sylvie Vincent, Steven Tyler, Clinical Cancer Research	2014	61
Spectroscopic Characterization of a DNA-Binding Domain, Zα, from the Editing Enzyme, dsRNA Adenosine Deaminase: Evidence for Left-Handed Z-DNA in the Zα−DNA Complex Imre Berger, William M. Winston, Ramasamy Manoharan, Biochemistry	1998	60
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibody Kenna Shirasuna, Gerald Koelsch, Cynthia Seidel‐Dugan, Cancer Treatment and Research Communications	2021	15
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity Christopher J. Nirschl, Heather R. Brodkin, Celesztina Domonkos, Cancer Immunology Research	2023	15
Conditionally Activated IL-12 or IFNα Indukine™ Molecules Inhibit Syngeneic Lymphoma Tumor Growth in Mice, Induce Anti-Tumor Immune Responses and Are Tolerated in Non-Human Primates Philipp Steiner, Heather R. Brodkin, Josue Canales, Blood	2021	10

Page 1